Evidence map›Paper›PMID 32292551›Full record

ArticleACS medicinal chemistry letters2020

New 8-Nitroquinolinone Derivative Displaying Submicromolar

Julien Pedron, Clotilde Boudot, Jean-Yves Brossas, Emilie Pinault, Sandra Bourgeade-Delmas, Alix Sournia-Saquet, Elisa Boutet-Robinet, Alexandre Destere, Antoine Tronnet, Justine Bergé and 15 more

Open access · hybridAbstract read
In one paragraph

Article in ACS medicinal chemistry letters, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 7 institutions in 2 countries.

Julien PedronLCC-CNRS, Université de Toulouse, CNRS, UPS, 31077 Toulouse, France.
Clotilde BoudotUniversité de Limoges, UMR INSERM 1094, Faculté de Pharmacie, 2 rue du Dr Marcland, 87025 Limoges, France.
Jean-Yves BrossasAP-HP, Groupe Hospitalier Pitié-Salpêtrière, Service de Parasitologie Mycologie, 75013 Paris, France.
Emilie PinaultUniversité de Limoges, BISCEm Mass Spectrometry Platform, CBRS, 2 rue du Pr. Descottes, F-87025 Limoges, France.
Sandra Bourgeade-DelmasUMR 152 PharmaDev, Université de Toulouse, IRD, UPS, 31077 Toulouse, France.
Alix Sournia-SaquetLCC-CNRS, Université de Toulouse, CNRS, UPS, 31077 Toulouse, France.
Elisa Boutet-RobinetToxalim, Université de Toulouse, INRA, ENVT, INP-Purpan, UPS, 31077 Toulouse, France.
Alexandre DestereDepartment of Pharmacology, Toxicology and Pharmacovigilance, CHU Limoges, France, INSERM, UMR 1248, University of Limoges, F-87025 Limoges, France.
Antoine TronnetLCC-CNRS, Université de Toulouse, CNRS, UPS, 31077 Toulouse, France.
Justine BergéLCC-CNRS, Université de Toulouse, CNRS, UPS, 31077 Toulouse, France.
Colin BonduelleLCC-CNRS, Université de Toulouse, CNRS, UPS, 31077 Toulouse, France.
Céline DeraeveLCC-CNRS, Université de Toulouse, CNRS, UPS, 31077 Toulouse, France.
Geneviève PratvielLCC-CNRS, Université de Toulouse, CNRS, UPS, 31077 Toulouse, France.
Jean-Luc StiglianiLCC-CNRS, Université de Toulouse, CNRS, UPS, 31077 Toulouse, France.
Luc ParisAP-HP, Groupe Hospitalier Pitié-Salpêtrière, Service de Parasitologie Mycologie, 75013 Paris, France.
Dominique MazierCIMI-Paris, Sorbonne Université, 91 Boulevard de l'Hôpital, 75013 Paris, France.
Sophie CorvaisierCentre d'Etudes et de Recherche sur le Médicament de Normandie (CERMN), Normandie Université, 14032 Caen, France.
Marc SinceCentre d'Etudes et de Recherche sur le Médicament de Normandie (CERMN), Normandie Université, 14032 Caen, France.
Aurélie Malzert-FréonCentre d'Etudes et de Recherche sur le Médicament de Normandie (CERMN), Normandie Université, 14032 Caen, France.
Susan WyllieUniversity of Dundee, School of Life Sciences, Division of Biological Chemistry and Drug Discovery, Dow Street, Dundee DD1 5EH, United Kingdom.
Rachel MilneUniversity of Dundee, School of Life Sciences, Division of Biological Chemistry and Drug Discovery, Dow Street, Dundee DD1 5EH, United Kingdom.
Alan H FairlambUniversity of Dundee, School of Life Sciences, Division of Biological Chemistry and Drug Discovery, Dow Street, Dundee DD1 5EH, United Kingdom.
Alexis ValentinUMR 152 PharmaDev, Université de Toulouse, IRD, UPS, 31077 Toulouse, France.
Bertrand CourtiouxUniversité de Limoges, UMR INSERM 1094, Faculté de Pharmacie, 2 rue du Dr Marcland, 87025 Limoges, France.
Pierre VerhaegheLCC-CNRS, Université de Toulouse, CNRS, UPS, 31077 Toulouse, France.
Centre National de la Recherche Scientifique · FRInserm · FRNormandie Université · FRSorbonne Université · FRUniversité Toulouse III - Paul Sabatier · FRUniversity of Dundee · GBUniversité de Limoges · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An antikinetoplastid pharmacomodulation study was conducted at position 6 of the 8-nitroquinolin-2(1

Identifiers

PMID32292551
PMCPMC7153024
OpenAlexW3005361943

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.